Another report by Kevin Lu et al. (2017) demonstrated the role of dipeptidylpeptidase-3 (DPP3) overexpression in modulating Nrf2/Keap1 signaling, which led to a chemotherapeutic drug resistance and progression of BC [211]. Here, KEAP1 is linked to breast cancer.